- Home
- Publications
- Publication Search
- Publication Details
Title
Hypoxia: The Cornerstone of Glioblastoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 22, Pages 12608
Publisher
MDPI AG
Online
2021-11-30
DOI
10.3390/ijms222212608
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxia and the phenomenon of immune exclusion
- (2021) Violena Pietrobon et al. Journal of Translational Medicine
- The Roles of HIF-1α in Radiosensitivity and Radiation-Induced Bystander Effects Under Hypoxia
- (2021) Jianghong Zhang et al. Frontiers in Cell and Developmental Biology
- The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia
- (2021) Xing-chen Ding et al. Journal of Hematology & Oncology
- cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
- (2020) Daniel J. Brat et al. ACTA NEUROPATHOLOGICA
- The significance of exosomes in the development and treatment of hepatocellular carcinoma
- (2020) Xin Li et al. Molecular Cancer
- AnvirzelTMregulates cell death through inhibiting GSK-3 activity in human U87 glioma cells
- (2020) Sule Terzioglu-Usak et al. NEUROLOGICAL RESEARCH
- Mitochondrial MUL1 E3 ubiquitin ligase regulates Hypoxia Inducible Factor (HIF-1α) and metabolic reprogramming by modulating the UBXN7 cofactor protein
- (2020) Lucia Cilenti et al. Scientific Reports
- Phase Ib clinical trial of OKN-007 in recurrent malignant glioma.
- (2020) James D. Battiste et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma
- (2020) Bhavesh K. Ahir et al. MOLECULAR NEUROBIOLOGY
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- Hypoxia-Driven Immune Escape in the Tumor Microenvironment
- (2020) Alyssa Vito et al. Cells
- SRC Tyrosine Kinase Inhibitor and X-rays Combined Effect on Glioblastoma Cell Lines
- (2020) Filippo Torrisi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evidence for hypoxia increasing the tempo of evolution in glioblastoma
- (2020) David Robert Grimes et al. BRITISH JOURNAL OF CANCER
- Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
- (2020) Faiqa Mudassar et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds
- (2020) Zhaowu Ma et al. SEMINARS IN CANCER BIOLOGY
- Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor
- (2020) Jaclyn J. Renfrow et al. Scientific Reports
- The Role of Hypoxia and SRC Tyrosine Kinase in Glioblastoma Invasiveness and Radioresistance
- (2020) Filippo Torrisi et al. Cancers
- Investigating Glioblastoma Response to Hypoxia
- (2020) Agathe L. Chédeville et al. Biomedicines
- Revisiting the Warburg effect: historical dogma versus current understanding
- (2020) Peter Vaupel et al. JOURNAL OF PHYSIOLOGY-LONDON
- The role of hypoxia‐inducible factor 1 in tumor immune evasion
- (2020) Li You et al. MEDICINAL RESEARCH REVIEWS
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism
- (2019) Ilias Mylonis et al. Cells
- HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma
- (2019) Jason Miska et al. Cell Reports
- Tumor angiogenesis: causes, consequences, challenges and opportunities
- (2019) Roberta Lugano et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Small cell carcinoma of the urinary bladder: a Clinicopathologic and Immunohistochemical analysis of 81 cases
- (2018) Gang Wang et al. HUMAN PATHOLOGY
- The role of hypoxia-inducible factor-2 alpha in angiogenesis
- (2018) Christina Befani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma
- (2018) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- WHO 2016 Classification of gliomas
- (2018) P. Wesseling et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Bevacizumab and Glioblastoma
- (2018) Michelle M. Kim et al. CANCER JOURNAL
- PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)
- (2018) Youbang Xie et al. Molecular Medicine Reports
- The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma
- (2018) Sihua Huang et al. ONCOLOGY REPORTS
- LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1α Expression
- (2017) Zhi-Gang Yao et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Phase II trial of dacomitinib, a pan–human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification
- (2017) Juan Manuel Sepúlveda-Sánchez et al. NEURO-ONCOLOGY
- Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells
- (2017) Nicole Colwell et al. NEURO-ONCOLOGY
- The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth
- (2017) Hyun Seung Ban et al. Cell Death & Disease
- Crosstalk between M2 macrophages and glioma stem cells
- (2017) Leora M. Nusblat et al. CELLULAR ONCOLOGY
- The Role of Hypoxia in Glioblastoma Invasion
- (2017) Ana Monteiro et al. Cells
- Results from a phase I, dose-escalation study of PX-478, an orally available inhibitor of HIF-1α.
- (2017) R. Tibes et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study of once-weekly aminoflavone prodrug (AFP464) in solid tumor patients.
- (2017) M. P. Goetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment
- (2016) Jun-Hai Tang et al. EXPERIMENTAL CELL RESEARCH
- Advances in the targeting of HIF-1α and future therapeutic strategies for glioblastoma multiforme
- (2016) Gang Wang et al. ONCOLOGY REPORTS
- Glioblastoma, hypoxia and autophagy: a survival-prone ‘ménage-à-trois’
- (2016) Soha Jawhari et al. Cell Death & Disease
- A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma
- (2016) Nageatte Ibrahim et al. Cancer Medicine
- Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1αsignalling
- (2015) Bo Xu et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism
- (2015) H. Shen et al. MOLECULAR CANCER THERAPEUTICS
- Immunosuppressive mechanisms in glioblastoma: Fig. 1.
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- Hypoxia-inducible factors in cancer stem cells and inflammation
- (2015) Gong Peng et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Monoamine oxidase B levels are highly expressed in human gliomas and are correlated with the expression of HiF-1α and with transcription factors Sp1 and Sp3
- (2015) Martyn A. Sharpe et al. Oncotarget
- Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies
- (2015) Agnieszka Zimna et al. Biomed Research International
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- Cancer stem cells and radioresistance
- (2014) Kiera Rycaj et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- MDM2 Regulates Hypoxic Hypoxia-inducible Factor 1α Stability in an E3 Ligase, Proteasome, and PTEN-Phosphatidylinositol 3-Kinase-AKT-dependent Manner
- (2014) Shweta Joshi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection
- (2014) Stephen M. Hatfield et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma
- (2014) Carlos Afonso Clara et al. NEUROPATHOLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- Fatty Acid Uptake and Lipid Storage Induced by HIF-1α Contribute to Cell Growth and Survival after Hypoxia-Reoxygenation
- (2014) Karim Bensaad et al. Cell Reports
- Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors
- (2013) Woondong Jeong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
- (2013) I. B. Barsoum et al. CANCER RESEARCH
- GRIM-19 opposes reprogramming of glioblastoma cell metabolism via HIF1α destabilization
- (2013) Qian Liu et al. CARCINOGENESIS
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- The expression of hypoxia-inducible factor-1 in primary brain tumors
- (2013) Joanna Reszec et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- PTEN status mediates 2ME2 anti-tumor efficacy in preclinical glioblastoma models: role of HIF1α suppression
- (2013) Carrie R. Muh et al. JOURNAL OF NEURO-ONCOLOGY
- HIF-1α inhibition sensitizes pituitary adenoma cells to temozolomide by regulating MGMT expression
- (2013) WENNA CHEN et al. ONCOLOGY REPORTS
- Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in Glioblastoma
- (2012) Y.-L. Hu et al. CANCER RESEARCH
- Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1 Interaction with Cofactors p300/CBP
- (2012) S. Yin et al. CLINICAL CANCER RESEARCH
- Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma
- (2012) ARNULF MAYER et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Hypoxia-related molecules HIF-1α, CA9, and osteopontin
- (2012) O.P. Erpolat et al. STRAHLENTHERAPIE UND ONKOLOGIE
- BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression
- (2012) L Persano et al. Cell Death & Disease
- Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects
- (2011) Puja Sapra et al. ANGIOGENESIS
- Angiopoietin 2 Stimulates TIE2-Expressing Monocytes To Suppress T Cell Activation and To Promote Regulatory T Cell Expansion
- (2011) Seth B. Coffelt et al. JOURNAL OF IMMUNOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
- (2011) B. Raychaudhuri et al. NEURO-ONCOLOGY
- Degradation of HIF-1alpha under Hypoxia Combined with Induction of Hsp90 Polyubiquitination in Cancer Cells by Hypericin: a Unique Cancer Therapy
- (2011) Tilda Barliya et al. PLoS One
- The IGFR1 inhibitor NVP-AEW541 disrupts a pro-survival and pro-angiogenic IGF-STAT3-HIF1 pathway in human glioblastoma cells
- (2010) Marzia B. Gariboldi et al. BIOCHEMICAL PHARMACOLOGY
- Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1 Expression in an AhR-Independent Fashion
- (2010) E. Terzuoli et al. CANCER RESEARCH
- The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
- (2010) John M. Heddleston et al. CELL CYCLE
- Knock down of HIF-1α in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres
- (2010) Olga Méndez et al. Molecular Cancer
- The expression and significance of HIF-1α and GLUT-3 in glioma
- (2009) Yang Liu et al. BRAIN RESEARCH
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
- (2009) Zhizhong Li et al. CANCER CELL
- Identification of a Novel Small Molecule HIF-1 Translation Inhibitor
- (2009) T. Narita et al. CLINICAL CANCER RESEARCH
- Inhibiting the Hypoxia Response for Cancer Therapy: The New Kid on the Block
- (2009) M. Y. Koh et al. CLINICAL CANCER RESEARCH
- Development of HIF-1 inhibitors for cancer therapy
- (2009) Barbara Onnis et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Quantitative Phosphoproteomic Analysis of the STAT3/IL-6/HIF1α Signaling Network: An Initial Study in GSC11 Glioblastoma Stem Cells
- (2009) Carol L. Nilsson et al. JOURNAL OF PROTEOME RESEARCH
- Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible Factor Induction of BNIP3 and BNIP3L via Their BH3 Domains
- (2009) G. Bellot et al. MOLECULAR AND CELLULAR BIOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells
- (2009) K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
- (2009) K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1
- (2009) S. Zhao et al. SCIENCE
- UBXD7 Binds Multiple Ubiquitin Ligases and Implicates p97 in HIF1α Turnover
- (2008) Gabriela Alexandru et al. CELL
- Expression of hypoxia inducible factor-1α in tumors of patients with glioblastoma multiforme and transitional meningioma
- (2008) Mehmet Yasar Kaynar et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1
- (2008) M. Y. Koh et al. MOLECULAR CANCER THERAPEUTICS
- A RNA antagonist of hypoxia-inducible factor-1 , EZN-2968, inhibits tumor cell growth
- (2008) L. M. Greenberger et al. MOLECULAR CANCER THERAPEUTICS
- Digoxin and other cardiac glycosides inhibit HIF-1 synthesis and block tumor growth
- (2008) H. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started